These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 23674772)
21. A software system for interventional magnetic resonance image-guided prostate brachytherapy. Kooy HM; Cormack RA; Mathiowitz G; Tempany C; D'Amico AV Comput Aided Surg; 2000; 5(6):401-13. PubMed ID: 11295853 [TBL] [Abstract][Full Text] [Related]
22. Organ-confined prostate carcinoma radiation brachytherapy compared with external either photon- or hadron-beam radiation therapy. Just a short up-to-date. Alberti C Eur Rev Med Pharmacol Sci; 2011 Jul; 15(7):769-74. PubMed ID: 21780545 [TBL] [Abstract][Full Text] [Related]
23. Dynamic MRI and CAD vs. choline MRS: where is the detection level for a lesion characterisation in prostate cancer? Schmuecking M; Boltze C; Geyer H; Salz H; Schilling B; Wendt TG; Kloetzer KH; Marx C Int J Radiat Biol; 2009 Sep; 85(9):814-24. PubMed ID: 19701842 [TBL] [Abstract][Full Text] [Related]
24. MRI-guided localization of the dominant intraprostatic lesion and dose analysis of volumetric modulated arc therapy planning for prostate cancer. Tamihardja J; Zenk M; Flentje M Strahlenther Onkol; 2019 Feb; 195(2):145-152. PubMed ID: 30209535 [TBL] [Abstract][Full Text] [Related]
25. Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy. Claus FG; Hricak H; Hattery RR Radiographics; 2004 Oct; 24 Suppl 1():S167-80. PubMed ID: 15486239 [TBL] [Abstract][Full Text] [Related]
27. [Application of image guided radiation therapy]. Nurmi H; Kauko S; Mikko T Duodecim; 2013; 129(7):721-9. PubMed ID: 23720941 [TBL] [Abstract][Full Text] [Related]
28. Use of conformal high-dose rate brachytherapy for management of patients with prostate cancer: optimizing dose escalation. Vicini FA; Kestin LL; Martinez AA Tech Urol; 2000 Jun; 6(2):135-45. PubMed ID: 10798815 [TBL] [Abstract][Full Text] [Related]
29. [Radiotherapy for localized prostate cancer (with and without hormonal treatment)]. Richaud P Rev Prat; 2013 Apr; 63(4):503-8. PubMed ID: 23682478 [TBL] [Abstract][Full Text] [Related]
30. Power against prostate cancer. Intensity-modulated radiation therapy and interstitial brachytherapy. Cash JC Adv Nurse Pract; 2006 Sep; 14(9):37-42. PubMed ID: 16972442 [No Abstract] [Full Text] [Related]
32. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy. Mock U; Bogner J; Georg D; Auberger T; Pötter R Strahlenther Onkol; 2005 Jul; 181(7):448-55. PubMed ID: 15995838 [TBL] [Abstract][Full Text] [Related]
33. Dosimetric and radiobiologic comparison of 3D conformal versus intensity modulated planning techniques for prostate bed radiotherapy. Koontz BF; Das S; Temple K; Bynum S; Catalano S; Koontz JI; Montana GS; Oleson JR Med Dosim; 2009; 34(3):256-60. PubMed ID: 19647638 [TBL] [Abstract][Full Text] [Related]
34. Technological advances in radiotherapy for the treatment of localised prostate cancer. Mangar SA; Huddart RA; Parker CC; Dearnaley DP; Khoo VS; Horwich A Eur J Cancer; 2005 Apr; 41(6):908-21. PubMed ID: 15808957 [TBL] [Abstract][Full Text] [Related]
35. Counterpoint: Opportunities and challenges of a magnetic resonance imaging-only radiotherapy work flow. Nyholm T; Jonsson J Semin Radiat Oncol; 2014 Jul; 24(3):175-80. PubMed ID: 24931088 [TBL] [Abstract][Full Text] [Related]
36. A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy. Myrehaug S; Chan G; Craig T; Weinberg V; Cheng C; Roach M; Cheung P; Sahgal A Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e657-62. PubMed ID: 22245189 [TBL] [Abstract][Full Text] [Related]
37. Image guided, adaptive, accelerated, high dose brachytherapy as model for advanced small volume radiotherapy. Haie-Meder C; Siebert FA; Pötter R Radiother Oncol; 2011 Sep; 100(3):333-43. PubMed ID: 21963284 [TBL] [Abstract][Full Text] [Related]
38. Creation of 3-dimensional prostate cancer maps: methodology and clinical and research implications. Malone SC; Haridass A; Nyiri B; Croke J; Malone C; Breau RH; Morash C; Avruch L; Daneshmand M; Malone K; Delatour NR; Ahmed I; Belanger E Arch Pathol Lab Med; 2014 Jun; 138(6):803-8. PubMed ID: 24878019 [TBL] [Abstract][Full Text] [Related]